Diagnostics
-
Hologic to go private for up to $18.3B
Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.
By Elise Reuter • Oct. 21, 2025 -
AdvaMed calls for series of trade actions in response to Section 232 probe
In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a tariff-free trading bloc with trusted countries among its proposals.
By Susan Kelly • Oct. 20, 2025 -
Explore the Trendline➔
Permission granted by Boston ScientificTrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
BD CFO Chris DelOrefice leaving for new job
Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.
By Susan Kelly • Oct. 16, 2025 -
Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout
The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, Kihealth raised $5 million in seed funding to launch its early detection test.
By Susan Kelly • Oct. 6, 2025 -
CDRH shares regulatory guidance priorities for the coming 12 months
Use of real-world evidence to support regulatory decisions and predetermined change control plans for medical devices are two areas of focus for the agency.
By Nick Paul Taylor • Oct. 2, 2025 -
MedTech Europe pressures EU to make regulatory changes by early 2026
The request includes a call to postpone re-certification requirements for devices already certified under the medical technology regulations.
By Nick Paul Taylor • Sept. 26, 2025 -
Quest to distribute Guardant colon cancer blood test
Guardant Health Co-CEO AmirAli Talasaz also unveiled plans to launch the Shield test for multi-cancer detection in October.
By Susan Kelly • Sept. 25, 2025 -
Multi-cancer blood tests aren’t ready for routine use, review says
Research funded by the Agency for Healthcare Research and Quality found insufficient evidence to determine the accuracy — or possible harm — of the cancer screenings.
By Susan Kelly • Sept. 23, 2025 -
FDA rescinds LDT final rule
Regulation of lab developed tests returns to its status before the agency attempted to expand its jurisdiction and industry groups sued to stop it.
By Susan Kelly • Sept. 19, 2025 -
House committee advances Medicare coverage bill for breakthrough devices
AdvaMed welcomed the committee’s work on the legislation but called for the inclusion of diagnostics in the bill.
By Nick Paul Taylor • Sept. 18, 2025 -
New bill would reform lab test payment rates
The bipartisan legislation, introduced this week in the House and Senate, seeks to prevent more cuts to Medicare reimbursement rates for diagnostic tests.
By Susan Kelly • Sept. 12, 2025 -
Medtech VC funding on track to hit highest value since 2021: PitchBook
“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.
By Nick Paul Taylor • Sept. 2, 2025 -
Quest forms joint venture with Corewell Health
The diagnostics company will open a lab with Corewell Health in 2027 and manage the not-for-profit health system’s existing lab facilities.
By Nick Paul Taylor • Aug. 27, 2025 -
Tempus inks $81M Paige buyout to support AI model development
CEO Eric Lefkofsky said that buying Paige “substantially accelerates” Tempus’ effort to build the largest foundation model in oncology.
By Nick Paul Taylor • Aug. 26, 2025 -
US to maintain lower tariff rates on China imports for 90 more days
China also extended its suspension of additional retaliatory duties against U.S. goods, maintaining current rates until November.
By Max Garland • Aug. 12, 2025 -
Earnings & Tariffs
GE HealthCare projects reduced tariff expense
Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger order growth.
By Susan Kelly • July 30, 2025 -
Quest, Labcorp downplay ‘Big Beautiful Bill’ impact
Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and domestic policy bill, including cuts to Medicaid, will be minimal.
By Susan Kelly • July 29, 2025 -
Labcorp to buy some Community Health assets for $195M
The deal includes outreach laboratory services in 13 states. Community Health will continue to operate its inpatient and emergency department labs along with other hospital-based testing services.
By Susan Kelly • July 24, 2025 -
Agilent CFO Bob McMahon resigns
Rodney Gonsalves, corporate controller and principal accounting officer, will take on interim CFO duties. Analysts said the company’s reaffirmed third-quarter guidance should reassure investors.
By Susan Kelly • July 17, 2025 -
Earnings & Tariffs
Abbott lowers sales forecast on diagnostics decline, US funding cuts
Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.
By Elise Reuter • July 17, 2025 -
Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test
The company plans to make the diagnostic available to physicians and researchers this summer, expanding its portfolio beyond laboratory developed tests.
By Nick Paul Taylor • July 15, 2025 -
Waters, BD biosciences unit agree to $17.5B merger
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading Monday on the news.
By Susan Kelly • July 14, 2025 -
Danaher appoints Martin Stumpe as chief technology and AI officer
The company said Stumpe’s promotion is a “pivotal step in [its] digital transformation and its ambition to lead the next era of innovation in life sciences and diagnostics.”
By Nick Paul Taylor • June 30, 2025 -
MedTech Europe urges EU to exclude devices, diagnostics from trade war
MedTech Europe said the EU’s list of products it could target in retaliation for U.S. actions “includes over 800 trade codes related to medical technologies.”
By Nick Paul Taylor • June 23, 2025 -
Illumina to buy SomaLogic for up to $425M
Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X products.
By Susan Kelly • June 23, 2025